Outcome of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in real-life setting

AIMS: To evaluate outcome of anti-vascular endothelial growth factor (VEGF) therapy for the treatment of neovascular age-related macular degeneration (nAMD) in the real-life setting and to compare incidence of ocular serious adverse events (SAE) after injections administered by nurses and physicians...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataja, Maria, Hujanen, Pekko, Huhtala, Heini, Kaarniranta, Kai, Tuulonen, Anja, Uusitalo-Jarvinen, Hannele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047152/
https://www.ncbi.nlm.nih.gov/pubmed/29074495
http://dx.doi.org/10.1136/bjophthalmol-2017-311055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047152/
https://www.ncbi.nlm.nih.gov/pubmed/29074495
http://dx.doi.org/10.1136/bjophthalmol-2017-311055

Ejemplares similares